New Light on Fetal Origins of Adult Disease

Human prenatal development can be viewed as a program of genetic switches that turn on, in a highly regulated manner, at specific places and times. But a body of evidence is emerging that paints a less hardwired picture, one of responses to environmental challenges fostering changes early on that reverberate decades later, in the guise of cardiovascular disease and diabetes. A symposium at the American Society of Human Genetics annual meeting, held in Philadelphia Oct. 3-7, addressed the fetal o

Written byRicki Lewis
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Human prenatal development can be viewed as a program of genetic switches that turn on, in a highly regulated manner, at specific places and times. But a body of evidence is emerging that paints a less hardwired picture, one of responses to environmental challenges fostering changes early on that reverberate decades later, in the guise of cardiovascular disease and diabetes. A symposium at the American Society of Human Genetics annual meeting, held in Philadelphia Oct. 3-7, addressed the fetal origin of adult diseases. Peter Nathaneilsz "Most people have Brave New World all wrong. The book that supposedly says that we are the products of our genes really means we are the products of the environment," said Peter Nathanielsz, the J. Law professor of physiology at Cornell University College of Veterinary Medicine. He was referring to the "epsilon" class of fetuses in Aldous Huxley's famed novel who were treated with ethanol ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies